Skip to content

Insider · CIK 0001952229

Harrison R. Bane

presidentofficer

Files at SGRY (Surgery Partners, Inc.). First filing Feb 10, 2025, latest Sep 8, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $1.8M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

SGRY: Surgery Partners, Inc.

SGRYOct 9, 2026 · close 13.89

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
32Weak
SGRYsell
Surgery Partners, Inc.
$210k
9,339 shares
-7%+16% from low-33% from high
45Moderate
SGRYsell 5
Surgery Partners, Inc.
$98k
4,045 shares
-3%-
70Notable
SGRYsell 6
Surgery Partners, Inc.
$1.4M
56,315 shares
-34%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 4, 2025SGRY
Surgery Partners, Inc.
SOpen-market sale
Common Stock
-5,726$22.48$129k120,794Sep 8, 2025
Sep 4, 2025SGRY
Surgery Partners, Inc.
SOpen-market sale
Common Stock
-3,613$22.48$81k117,181Sep 8, 2025
Mar 10, 2025SGRY
Surgery Partners, Inc.
SOpen-market sale
Common Stock
-4,045$24.16$98k126,520Mar 13, 2025
Mar 4, 2025SGRY
Surgery Partners, Inc.
AGrant or award
Common Stock
+17,226$23.80$410k124,263Mar 6, 2025
Mar 4, 2025SGRY
Surgery Partners, Inc.
AGrant or award
Common Stock
+6,302$23.80$150k130,565Mar 6, 2025
Feb 7, 2025SGRY
Surgery Partners, Inc.
SOpen-market sale
Common Stock
-56,315$25.64$1.4M107,037Feb 10, 2025
Jan 31, 2025SGRY
Surgery Partners, Inc.
AGrant or award
Common Stock
+115,116$0.00$0163,352Feb 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Harrison R. Bane: insider trades and track record | InsiderTell